This 2012 pilot study assessed the lipid-lowering effects of berberine in obese human subjects and Sprague-Dawley rats. Participants received 500 mg of berberine orally three times daily for 12 weeks. In humans, berberine administration resulted in a significant reduction in triglyceride levels by 23% and total cholesterol by 12.2%, along
This 2020 systematic review and meta-analysis evaluated the effects of berberine supplementation on obesity-related parameters, inflammation, and liver function enzymes. Analyzing 12 randomized controlled trials, the study found that berberine intake led to significant reductions in body weight (mean difference: -2.07 kg), body mass index (BMI), waist circumference, and C-reactive
This post-hoc analysis of a Phase 1/2 randomized, placebo-controlled trial evaluated the efficacy of systemic administration of bone marrow-derived allogeneic mesenchymal stromal cells (remestemcel-L) in COPD patients stratified by baseline C-reactive protein (CRP) levels. In patients with CRP ≥ 4 mg/L, remestemcel-L treatment led to significant improvements in forced expiratory
This comprehensive review examines the scientific foundations and efficacy of emerging anti-aging strategies aimed at promoting healthier aging and mitigating age-related diseases. Key interventions discussed include caloric restriction, intermittent fasting, senolytics, sirtuin-activating compounds, NAD+ precursors, and stem cell therapies. The review highlights the mechanisms by which these strategies influence aging
This Phase II randomized, double-blind, placebo-controlled trial assessed the safety and efficacy of intravenous allogeneic human mesenchymal stem cells (allo-hMSCs) in 30 elderly patients (mean age 75.5 years) with aging frailty. Participants received either 100 million or 200 million allo-hMSCs or placebo. No treatment-related serious adverse events were observed. The
This 2018 preclinical study investigated the effects of Metabolaid®, a combination of lemon verbena and hibiscus flower extracts, on obesity and metabolic parameters in high-fat diet-induced obese mice. The treatment led to significant reductions in body weight, white adipose tissue, and liver weight. Improvements were observed in serum and hepatic
This 2013 review explores the relationship between gut microbiota composition and obesity. It highlights that obese individuals often exhibit a higher Firmicutes-to-Bacteroidetes ratio, which may enhance energy extraction from the diet. Animal studies demonstrate that transferring microbiota from obese to lean mice can induce weight gain, suggesting a causal role
This 2012 review discusses emerging therapeutic strategies for dry age-related macular degeneration (AMD), focusing on approaches targeting oxidative stress, inflammation, and complement system dysregulation. Investigational treatments include complement inhibitors, neuroprotective agents, visual cycle modulators, and stem cell therapies. The article emphasizes the need for continued research to develop effective interventions
This 2014 review explores the mechanistic links between obesity and cancer, focusing on the role of triglyceride/free fatty acid (TG/FFA) cycling. Obesity-induced alterations in lipid metabolism lead to increased availability of FFAs, which can promote tumorigenesis through various pathways, including enhanced energy supply for rapidly proliferating cancer cells, modulation of
This 2011 study explores the role of mast cells in obesity and type 2 diabetes, demonstrating that mast cell deficiency or pharmacological stabilization with agents like cromolyn and ketotifen reduces body weight gain and improves glucose and insulin sensitivities in mice. The research indicates that mast cells contribute to these
